EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial

Chloe Howard iD, David W Johnson iD, Carmel M Hawley, Kylie Pegg, Hannah Mayr, Diana Leary, Rachael Hale, Andrea K Viecelli, Janette Hamilton, Vicki Thomas, Irish Dela-Pena, Yeoungjee Cho iD

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2026

DOI: 10.1177/08968608261429654 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2026. Verfasst von Chloe Howard und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Psyllium, Peritoneal Dialysis, Constipation, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Queensland Health, PA Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients receiving peritoneal dialysis (PD) often report problems with constipation. Constipation in PD is associated with increased risks of mechanical and infectious complications, such as poor drainage and fluid removal, catheter migration and peritonitis. A natural fibre supplement, psyllium husk, has been identified as a potential alternative therapy to minimise the risk of constipation for patients receiving PD.

Methods

FIBRE-PD is a prospective parallel-arm open-label feasibility study in which patients on PD were 1:1 randomly assigned to receive either psyllium husk (intervention group) or continue routine Movicol ® (control group) for four weeks (28 days). The primary outcome was feasibility, defined as successful recruitment of 60 patients, representing 70% of eligible PD patients. Secondary outcomes included adherence, retention, safety, bowel frequency and patient-reported outcomes (e.g., gastrointestinal symptom burden, quality of life).

Results

Overall, 96 patients were screened for eligibility. Sixty-six (69%) were deemed not eligible, mainly due to non-adherence to prescribed regular Movicol ( n = 41, 62%). Among 30 eligible patients, 20 patients (67% of eligible population) were successfully recruited into the study. The intervention group demonstrated high retention (77%), adherence rates (78%) and significant improvement in gastrointestinal symptoms and quality of life compared to patients in the control group. No adverse outcomes were reported.

Conclusion

The FIBRE-PD did not meet its original recruitment target due to an unexpectedly high number of ineligible patients. The recruited proportion almost reached the pre-specified target of 70% of eligible patients, and participants in the intervention group demonstrated high retention and adherence rates with observed benefits in gastrointestinal symptom burden and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsylliumPeritoneal DialysisConstipationKidney Failure, ChronicDietary FiberHumansFemaleFeasibility StudiesProspective StudiesMaleMiddle AgedPilot ProjectsQuality of LifePatient ComplianceAgedAdult

Stichwörter der Autor:innen

ConstipationMovicol®fibreoutcomeperitoneal dialysispsyllium

Substanzen

PsylliumDietary Fiber

Autor:innen und Institutionen

  • Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Australasian Kidney Trials Network at the Faculty of Health, Medicine and Behavioural Science at the University of Queensland, Brisbane, QLD, Australia.
  • Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Greater Brisbane Clinical School, Faculty of Health, Medicine and Behavioural Science, the University of Queensland, Brisbane, QLD, Australia.

ORCID-Profile: Chloe Howard, David W Johnson, Yeoungjee Cho

Förderung

  • Queensland Health
  • PA Research Foundation

Zitieren

APA

Howard, C., Johnson, D. W., Hawley, C. M., Pegg, K., Mayr, H., Leary, D., Hale, R., Viecelli, A. K., Hamilton, J., Thomas, V., Dela-Pena, I., & Cho, Y. (2026). Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. https://doi.org/10.1177/08968608261429654

Vancouver

Howard C, Johnson DW, Hawley CM, Pegg K, Mayr H, Leary D, et al. Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2026. doi:10.1177/08968608261429654

BibTeX
@article{Howard2026,
  author = {Howard, Chloe and Johnson, David W and Hawley, Carmel M and Pegg, Kylie and Mayr, Hannah and Leary, Diana and Hale, Rachael and Viecelli, Andrea K and Hamilton, Janette and Thomas, Vicki and Dela-Pena, Irish and Cho, Yeoungjee},
  title = {Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial},
  journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
  year = {2026},
  doi = {10.1177/08968608261429654}
}
Kostenlos starten →